Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

3 Small-Cap Healthcare Stocks Wall Street Loves

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….

StockNews.com

Abortion pill access is unchanged after the Supreme Court's decision. Here's what you need to know

A unanimous Supreme Court ruling means the abortion pill mifepristone remains available, including via mail delivery

The Independent UK

Supreme Court Upholds FDA Approval Process For Abortion Drug

Supreme Court ruling on FDA's mifepristone regulations post-Dobbs v. Jackson Women’s Health Organization overturning Roe v. Wade, emphasizing engagement in...

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

Supreme Court throws out challenge to key abortion pill mifepristone

Supreme Court rejected conservative group’s attempt to restrict access to abortion pill medication but left the door open for further lawsuits

The Independent UK

3 Biotech Stocks for Investing in the Future

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

StockNews.com

Is the British Gas boss really worth £8.2m?

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control

The Guardian - UK

Need a pharmacy? These states and neighborhoods have less access

Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

French Pharmacists Strike Over Pay And Drug Shortages

French pharmacists began their first walkout in 10 years on Thursday, closing up shop over drug shortages, low regulated prices, pharmacy closures and fears medications could be sold online.

International Business Times

AMD willing to pay you up to $30k via its new bug bounty program

AMD expands its private bug bounty program to the general public, allowing anyone who signs up for an Intigriti account to submit bugs and get paid.

Tom’s Hardware

Texas revamps Narcan distribution following delays, unpredictable supply

Texas has tapped more than $45 million in federal funds to get the overdose-reversing drug into the hands of law enforcement, members of the public. But the program has been plagued by supply issues, delays and lack of communication.

The Texas Tribune

French pharmacists strike to highlight drug shortages and demand better pay

In their first major strike in a decade, pharmacists across France stopped work on Thursday to draw attention to drug shortages, forced closures and potential restrictions on online sales. They also want higher pay.

Radio France Internationale

Pharma Firm Urged To Share New 'Game-changer' HIV Drug

More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing countries most affected by the deadly disease.

International Business Times

4 Pharma Stocks to Watch for Surprising Gains in June

Amid growing demand for specialty drugs and increasing adoption of emerging technology in pharmaceutical manufacturing, the pharma industry is witnessing steady expansion. Therefore, quality pharmaceutical stocks Zoetis (ZTS), Viatris (VTRS), MEI Pharma (MEIP), and Amphastar Pharmaceuticals (AMPH) could be ideal additions to your watchlist. Keep reading….

StockNews.com

3 Value Biotech Stocks With Breakout Potential in 2024

Given growing healthcare spending, supportive government policies, and technological innovation, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying quality biotech stocks Harmony Biosciences (HRMY), Esperion Therapeutics (ESPR), and Entrada Therapeutics (TRDA), which are trading at a discount. Read on….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

‘Facebook probably knows I sell drugs’ – how young people’s digital footprints can threaten their future prospects

Social media and messaging apps such as Facebook, Instagram, Snapchat and Messenger are increasingly used to buy and sell drugs in many countries. New Zealand is no exception.

The Guardian - UK

AstraZeneca aims to nearly double revenues to $80bn by 2030

UK’s biggest drugmaker says it plans to launch 20 major new medicines before the end of the decade

Evening Standard

'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030

The growth will be fuelled by 20 new drugs that are set to launch this decade

StockNews.com

3 Biotech Stocks Poised for May Surges

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Pharma Stocks Primed for May Investment Opportunities

The pharma industry is poised for tremendous growth driven by surging healthcare needs, the introduction of groundbreaking medications, and relentless technological innovation. Hence, quality pharma stocks Collegium Pharmaceutical (COLL), Green Thumb Industries (GTBIF), and Bristol-Myers Squibb (BMY) emerge as prime investment options this month. Read more….

The Guardian - UK

Imagine getting life-saving drugs to sick people without relying on big pharma? We may have found a way

An NHS trust’s attempts to bring a crucial drug to market itself is hopeful news for patients, says Dr Catriona Crombie of the medical charity LifeArc

StockNews.com

3 Pharma Stocks to Buy for Potential Financial Fortunes

Amid surging medicine demand and ongoing drug shortages, the pharmaceutical industry thrives, driving improved patient outcomes and promising growth opportunities for investors. So, it could be wise to invest in quality pharma stocks ACADIA Pharmaceuticals (ACAD), Neurocrine Biosciences (NBIX), and Supernus Pharmaceuticals (SUPN), which can help you fetch potential financial…

StockNews.com

3 Top-Rated Pharma Stocks to Diversify Your Portfolio

The pharmaceutical industry is expanding owing to the rising incidence of chronic diseases, increasing investments in R&D, and the use of advanced technologies for drug development and manufacturing. Given this backdrop, investors could consider buying quality pharma stocks such as Elanco Animal Health (ELAN), Viatris (VTRS), and Astellas Pharma (ALPMY),…

The Guardian - UK

AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten

Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

Dynamite News

Punjab Police busts inter-state illegal pharma supply and manufacturing network

Punjab Police busted an inter-state illegal pharmaceutical supply and manufacturing network operating from a pharma factory in Himachal Pradesh. Read further on Dynamite News:

StockNews.com

Buy Alert: 3 Pharma Stocks Under $20 to Invest in Now

With rising medicine demand and drug shortages in the U.S., pharmaceutical stocks under $20 present lucrative opportunities for investors, promising substantial returns in a ripe market. So, I think fundamentally solid pharma stocks ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), and OptiNose (OPTN), which are currently trading under $20, could be…

1 … 33 34 35 36

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations